MedFirst Healthcare Services, Inc. (TPEX:4175)
Taiwan · Delayed Price · Currency is TWD 57.90
-0.30 (-0.52%)
At close: Feb 11, 2026
TPEX:4175 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 7,945 | 7,734 | 7,446 | 7,224 | 6,540 | 5,927 | |
Revenue Growth (YoY) | 3.26% | 3.87% | 3.08% | 10.46% | 10.34% | 11.73% |
Cost of Revenue | 5,379 | 5,351 | 5,177 | 5,018 | 4,614 | 4,103 |
Gross Profit | 2,567 | 2,383 | 2,269 | 2,206 | 1,927 | 1,825 |
Selling, General & Admin | 2,342 | 2,260 | 2,164 | 1,979 | 1,815 | 1,671 |
Operating Expenses | 2,341 | 2,260 | 2,164 | 1,978 | 1,814 | 1,673 |
Operating Income | 225.69 | 123.06 | 105.51 | 227.71 | 113.22 | 151.46 |
Interest Expense | -60.24 | -58.94 | -58.43 | -46.8 | -37.4 | -24.68 |
Interest & Investment Income | 6.35 | 5.83 | 8.47 | 3.12 | 1.79 | 2.3 |
Currency Exchange Gain (Loss) | -0.15 | 3.12 | -0.81 | 11.04 | -1.52 | -3.95 |
Other Non Operating Income (Expenses) | 26.72 | 22.6 | 20.83 | 24.1 | 13.95 | 14.04 |
EBT Excluding Unusual Items | 198.38 | 95.67 | 75.56 | 219.17 | 90.04 | 139.17 |
Impairment of Goodwill | - | - | -5.29 | -2.3 | -3.61 | - |
Gain (Loss) on Sale of Investments | - | -0.01 | -0.29 | 0.29 | - | -0.87 |
Gain (Loss) on Sale of Assets | -0.51 | -0.51 | -0.27 | 0.87 | -22.85 | -0.38 |
Asset Writedown | -0.34 | -0.34 | -0.17 | - | -1.37 | - |
Legal Settlements | - | - | - | 0.85 | -7.57 | - |
Other Unusual Items | 1.74 | 0.57 | 0.34 | 3.08 | 0.88 | -7.29 |
Pretax Income | 199.27 | 95.39 | 69.89 | 221.96 | 58.96 | 130.62 |
Income Tax Expense | 36.42 | 25.4 | 22.36 | 46.28 | -7.33 | 26.17 |
Earnings From Continuing Operations | 162.85 | 69.99 | 47.53 | 175.68 | 66.29 | 104.46 |
Minority Interest in Earnings | 0.23 | -0.17 | -0.73 | -4.82 | 1.64 | 5.39 |
Net Income | 163.08 | 69.82 | 46.8 | 170.86 | 67.93 | 109.85 |
Net Income to Common | 163.08 | 69.82 | 46.8 | 170.86 | 67.93 | 109.85 |
Net Income Growth | 613.44% | 49.17% | -72.61% | 151.53% | -38.16% | -22.11% |
Shares Outstanding (Basic) | 42 | 42 | 42 | 39 | 38 | 37 |
Shares Outstanding (Diluted) | 43 | 42 | 42 | 42 | 42 | 41 |
Shares Change (YoY) | 0.49% | 0.07% | -0.18% | 0.32% | 3.20% | 7.86% |
EPS (Basic) | 3.85 | 1.65 | 1.13 | 4.41 | 1.80 | 2.96 |
EPS (Diluted) | 3.83 | 1.65 | 1.12 | 4.09 | 1.69 | 2.76 |
EPS Growth | 609.35% | 46.83% | -72.58% | 142.01% | -38.67% | -26.47% |
Free Cash Flow | 602.03 | 407.3 | 573.42 | 780 | 592.88 | 101.69 |
Free Cash Flow Per Share | 14.15 | 9.61 | 13.54 | 18.39 | 14.02 | 2.48 |
Dividend Per Share | 1.600 | 1.600 | 1.600 | 2.600 | 1.459 | 1.676 |
Dividend Growth | - | - | -38.45% | 78.13% | -12.94% | -45.00% |
Gross Margin | 32.30% | 30.81% | 30.47% | 30.53% | 29.46% | 30.78% |
Operating Margin | 2.84% | 1.59% | 1.42% | 3.15% | 1.73% | 2.56% |
Profit Margin | 2.05% | 0.90% | 0.63% | 2.37% | 1.04% | 1.85% |
Free Cash Flow Margin | 7.58% | 5.27% | 7.70% | 10.80% | 9.06% | 1.72% |
EBITDA | 409.43 | 304.9 | 287.19 | 396.14 | 266.93 | 267 |
EBITDA Margin | 5.15% | 3.94% | 3.86% | 5.48% | 4.08% | 4.50% |
D&A For EBITDA | 183.75 | 181.84 | 181.68 | 168.42 | 153.72 | 115.54 |
EBIT | 225.69 | 123.06 | 105.51 | 227.71 | 113.22 | 151.46 |
EBIT Margin | 2.84% | 1.59% | 1.42% | 3.15% | 1.73% | 2.56% |
Effective Tax Rate | 18.28% | 26.63% | 31.99% | 20.85% | - | 20.03% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.